Pharma Mar S.A. (PHM) — Cash Flow Reinvestment Rate

Latest as of December 2025: 1.74x

Pharma Mar S.A. (PHM) has a Cash Flow Reinvestment Rate of 1.74x as of December 2025, reinvesting €58.27 Million (capex €6.26 Million plus investments €-52.01 Million) from operating cash flow of €33.58 Million. See PHM free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

1.74x
(Capex + Investments) / Operating CF

Total Reinvested

€58.27 Million
Capex + Investments

Operating Cash Flow

€33.58 Million
EUR

Capital Expenditures

€6.26 Million
EUR

Pharma Mar S.A. Cash Flow Reinvestment Rate (2012–2025)

Historical reinvestment intensity for Pharma Mar S.A. across 9 annual periods. For the full cash flow conversion analysis, see PHM cash flow conversion.

Annual Cash Flow Reinvestment Rate for Pharma Mar S.A. (2012–2025)

Year-by-year capital reinvestment analysis for Pharma Mar S.A.. See financial agility of Pharma Mar S.A. to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2025 1.24x €65.69 Million €53.13 Million €9.38 Million ▼ -55.0%
2024 2.74x €16.54 Million €6.03 Million €15.51 Million ▲ +433.1%
2022 0.51x €19.73 Million €38.32 Million €8.85 Million ▼ -61.2%
2021 1.33x €34.08 Million €25.68 Million €7.80 Million ▲ +211.1%
2020 0.43x €119.01 Million €278.94 Million €3.00 Million ▼ -83.2%
2015 2.55x €28.26 Million €11.10 Million €9.22 Million ▲ +144.8%
2014 1.04x €22.99 Million €22.11 Million €10.18 Million ▲ +421.6%
2013 0.20x €3.26 Million €16.34 Million €2.10 Million ▼ -37.9%
2012 0.32x €2.03 Million €6.32 Million €2.03 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow